Lin, Chi <br/><br/>
Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.  [electronic resource] 

 -  American journal of clinical oncology  10 2019 
 - 755-760 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1537-453X 
<br/><br/><label>Standard No.: </label>10.1097/COC.0000000000000599  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnostic imaging<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>CA-125 Antigen--blood<br/>Camptothecin--adverse effects<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Female<br/>Fluorouracil--adverse effects<br/>Follow-Up Studies<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leucovorin--adverse effects<br/>Magnetic Resonance Imaging--methods<br/>Male<br/>Membrane Proteins--blood<br/>Middle Aged<br/>Nelfinavir--adverse effects<br/>Neoadjuvant Therapy--methods<br/>Neoplasm Invasiveness--pathology<br/>Organoplatinum Compounds--adverse effects<br/>Pancreatic Neoplasms--diagnostic imaging<br/>Pancreaticoduodenectomy--methods<br/>Proportional Hazards Models<br/>Radiosurgery--methods<br/>Risk Assessment<br/>Survival Analysis<br/>Time Factors<br/>Tomography, X-Ray Computed--methods<br/>Treatment Outcome